Make Systems, Inc.
Make Systems, Inc. is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Make Systems, Inc..
Make Systems, Inc. is a company.
Key people at Make Systems, Inc..
Key people at Make Systems, Inc..
MAK-SYSTEM is a software company specializing in innovative solutions for blood banking, transfusion services, tissue banks, and plasma centers, enabling efficient tracking, manufacturing, testing, and inventory management of blood components and derivatives to ensure safety and compliance in global supply chains.[1][2] Founded in 1984 and headquartered in Skopje, Macedonia with a U.S. office in Des Plaines, Illinois, it serves healthcare professionals worldwide, helping them improve patient outcomes by streamlining complex operations in blood management; the company reports around 217-220 employees and annual revenue between $13.5 million and $46.2 million.[1][2]
Its core product suite addresses critical challenges in healthcare supply chains, such as monitoring short-lived inventories and delivering safe products to patients, with recent expansions including the 2023 launch of MAK.care, a cloud platform in partnership with AWS for blood and biologics management.[2] This positions MAK-SYSTEM as a key enabler in life-saving healthcare technologies, demonstrating steady growth through specialized, proven software tailored to regulatory and operational demands.[1][2]
MAK-SYSTEM was founded in 1984, initially focusing on designing software for the intricate needs of blood banking and transfusion sectors, a niche born from the complexities of managing blood components and derivatives.[2] The company's evolution reflects a commitment to healthcare innovation, expanding from on-premise solutions to global cloud offerings, marked by the pivotal 2023 strategic partnership with Amazon Web Services (AWS) to launch MAK.care—a disruptive platform enhancing efficiency for blood and biologics worldwide.[2]
Key leadership includes Difa Niculescu as CTO, guiding technical advancements amid growth to over 180 employees tracked on professional networks.[1] Early traction stemmed from addressing proven needs in blood banks, hospital transfusion services, and plasma centers, building a 40-year track record in a highly regulated industry.[1][2]
MAK-SYSTEM rides the trend of digital transformation in healthcare supply chains, particularly in biologics and transfusion medicine, where rising demand for blood products—driven by aging populations, chronic diseases, and post-pandemic plasma needs—amplifies the need for precise, compliant software.[1][2] Timing is ideal amid cloud adoption in regulated sectors, as seen in its AWS-powered MAK.care launch, aligning with market forces like inventory shortages, regulatory pressures (e.g., FDA/EMA standards), and AI/cloud integration for real-time tracking.[2]
It influences the ecosystem by setting benchmarks for niche healthcare IT, enabling safer global blood supplies and supporting scalability for tissue/plasma operations, which indirectly bolsters broader medtech innovation in patient care and supply resilience.[1][2]
MAK-SYSTEM is poised for expansion through cloud-native solutions like MAK.care, potentially capturing more market share in growing biologics and personalized medicine sectors as AI enhances predictive inventory and compliance tools.[2] Trends such as increased global blood demand, stricter regulations, and hybrid cloud-on-premise models will shape its trajectory, with opportunities in emerging markets and integrations with telehealth or genomics platforms.
Its influence may evolve from specialized provider to ecosystem leader, fostering partnerships that standardize blood management worldwide—reinforcing its foundational role in enabling life-saving technologies amid healthcare's digital shift.[1][2]